Cindy B. McReynolds

Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative

Bruce D. Hammock, Cindy B. McReynolds, Alan R. Buckpitt et al. · Journal of Medicinal Chemistry · 2021 · 158 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections

Cindy B. McReynolds, Irene Cortés‐Puch, Resmi Ravindran et al. · Frontiers in Physiology · 2021 · 60 citations · Full text

Veterinary Medicine, Biochemistry, Pathobiology +17

sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury

Christian B. Bergmann, Cindy B. McReynolds, Debin Wan et al. · Proceedings of the National Academy of Sciences · 2022 · 60 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients

Dongyang Li, Christophe Morisseau, Cindy B. McReynolds et al. · Analytical Chemistry · 2020 · 49 citations · Full text

Life Sciences, Biochemistry, Immunology +14

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis

Cindy B. McReynolds, Sung Hee Hwang, Jun Yang et al. · Frontiers in Pharmacology · 2019 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17